Literature DB >> 7870194

Withdrawal from repeated morphine sensitizes mice to the striatal dopamine release enhancing effect of acute morphine.

J Airio1, M Attila, T Leikola-Pelho, L Ahtee.   

Abstract

The effects of morphine withdrawal and challenge on the alpha-methyl-rho-tyrosine (alpha MT)-induced depletion of dopamine (DA) as well as on DA metabolism and 3H-SCH 23390 and 3H-spiperone binding were studied in the striata of male mice. Morphine was given s.c. 3 times daily for 5 days followed by 1 to 3 days' withdrawal. The alpha MT-induced DA depletion was retarded in mice withdrawn for 1 day from repeated morphine. At this time point the striatal concentrations of 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) fell, too. In mice withdrawn for 3 days from morphine neither DA depletion nor DOPAC or HVA concentrations differed from those of control mice. In control mice acute morphine challenge accelerated the DA depletion at the dose 10 mg/kg but not at the dose 30 mg/kg. Both doses elevated striatal DOPAC and HVA. In mice withdrawn from repeated morphine for 1 day acute morphine partially counteracted the withdrawal-induced retardation of DA depletion and elevated striatal DOPAC and HVA clearly less than in control mice. However, in mice withdrawn for 3 days 10 mg/kg of morphine clearly enhanced DA depletion and its effect on striatal HVA was significantly augmented. In these mice as in controls the 30 mg/kg dose did not alter striatal DA depletion and elevated HVA less than in controls. Acute morphine did not alter striatal 3-methoxytyramine (3-MT) concentration in control mice but at the dose 10 mg/kg increased it in mice withdrawn for 3 days.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7870194     DOI: 10.1007/bf00173025

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  38 in total

1.  Sensitivity of morphine-tolerant rats to muscarinic and dopaminergic agonists: relation to tolerance or withdrawal.

Authors:  M J Christie; D H Overstreet
Journal:  Psychopharmacology (Berl)       Date:  1979-09       Impact factor: 4.530

2.  Stimulant effects of enkephalin microinjection into the dopaminergic A10 area.

Authors:  C L Broekkamp; A G Phillips; A R Cools
Journal:  Nature       Date:  1979-04-05       Impact factor: 49.962

3.  Changes in dopamine receptors in mouse striatum following morphine treatments.

Authors:  S de la Baume; G Patey; H Marçais; P Protais; J Costentin; J C Schwartz
Journal:  Life Sci       Date:  1979-06-18       Impact factor: 5.037

4.  Application of steady state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines.

Authors:  B B Brodie; E Costa; A Dlabac; N H Neff; H H Smookler
Journal:  J Pharmacol Exp Ther       Date:  1966-12       Impact factor: 4.030

5.  Differences in the effects of morphine on the alpha-methyl-p-tyrosine-induced depletion of dopamine and noradrenaline in various areas of the mouse brain.

Authors:  L Martti; J Attila; E Etemadzadeh; L Ahtee
Journal:  Pharmacol Toxicol       Date:  1987-07

6.  Monoamine mediation of the morphine-induced activation of mice.

Authors:  B J Carroll; P T Sharp
Journal:  Br J Pharmacol       Date:  1972-09       Impact factor: 8.739

7.  Binding of [3H]spiroperidol to striatal membranes of rats treated chronically with morphine. Influence of Pro-Leu-Gly-NH2 and cyclo(Leu-Gly).

Authors:  H N Bhargava
Journal:  Neuropharmacology       Date:  1983-12       Impact factor: 5.250

8.  On the significance of endogenous 3-methoxytyramine for the effects of centrally acting drugs on dopamine release in the rat brain.

Authors:  B H Westerink; S J Spaan
Journal:  J Neurochem       Date:  1982-03       Impact factor: 5.372

9.  Estimation of the turnover of 3-methoxytyramine in the rat striatum by HPLC with electrochemical detection: implications for the sequence in the cerebral metabolism of dopamine.

Authors:  B H Westerink; S J Spaan
Journal:  J Neurochem       Date:  1982-02       Impact factor: 5.372

10.  The fall of homovanillic acid and 5-hydroxyindoleacetic acid concentrations in brains of mice withdrawn from repeated morphine treatment and their restoration by acute morphine administration.

Authors:  L Ahtee; P Attila; V Lauhakangas; A Solkinen; J Sipilä
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

View more
  3 in total

1.  Different effects of opiate withdrawal on dopamine turnover, uptake, and release in the striatum and nucleus accumbens.

Authors:  S Ghosh; A H Patel; M Cousins; K Grasing
Journal:  Neurochem Res       Date:  1998-06       Impact factor: 3.996

2.  The involvement of noradrenergic transmission in the morphine-induced locomotor hyperactivity in mice withdrawn from repeated morphine treatment.

Authors:  J Airio; L Ahtee
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

3.  Presynaptic dopaminergic function in the nucleus accumbens following chronic opiate treatment and precipitated withdrawal.

Authors:  S Ghosh; K Grasing
Journal:  Neurochem Res       Date:  1999-01       Impact factor: 3.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.